• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Rectal cancer presentation and screening rates during the COVID-19 pandemic

byDavy LauandAlex Chan
September 18, 2023
in Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Despite the decrease in colonoscopies performed at the start of the COVID-19 pandemic, there was no difference in the percentage of colorectal cancer (CRC) presentations at a later stage or with higher acuity, when comparing patients diagnosed with rectal adenocarcinoma pre-pandemic and during the pandemic.

Evidence Rating Level: 2 (Good)

Colonoscopies as part of colorectal cancer (CRC) screening are instrumental in the early diagnosis of CRC, and have been associated with a 75% reduction in mortality for those diagnosed with left-sided colon cancer, likely due to earlier detection. However, during the initial months of the COVID-19 pandemic, there were cancellations of non-urgent procedures, resulting in a 90% relative reduction in scopes performed in the US and England in April 2020. Therefore, this retrospective study aimed to determine if the cancellations from the COVID-19 led to more acute presentations of rectal adenocarcinoma, or presentations at a later stage, in comparison to pre-pandemic times. The study population included all patients diagnosed with rectal adenocarcinoma between 2016 and 2021 at a single centre. Pre-COVID patients were defined as a diagnosis made before March 1, 2020. With regards to outcomes, an acute presentation was defined as a visit to the emergency department or admission to hospital with symptoms related to rectal cancer. In total, there were 208 patients included, 163 of which comprised the pre-COVID cohort. The results showed that the stage at presentation was similar, with the majority presenting with stage III (40.0% pre-COVID vs 33.3% COVID, p = 0.26). The rate of patients bleeding as the presenting complaint or presenting after CRC screening were similar as well (50.3% pre-COVID vs 42.2% COVID for bleeding, and 24.5% pre-COVID vs 24.4% for COVID respectively). Following adjustment for covariates, there was still no difference in acute presentation between the pre-COVID and COVID cohorts (odds ratio 1.24, 95% CI 0.57-2.72, p = 0.59). Overall, this study demonstrated that despite a decrease in CRC screening at the start of the COVID-19 pandemic, there was no increased proportion of acute CRC presentations or later stage, compared to pre-pandemic times.

Click to read the study in PLOSONE

Image: PD

©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine Rewind July 7, 2025

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

Tags: colorectal cancerCOVID-19Gastroenterologyoncologypublic healthscreening
Previous Post

Generic and brand-name fluticasone-salmeterol are equally effective in COPD management

Next Post

Adverse childhood experiences and current life stressors may moderate the relationship between depression and C-reactive protein in midlife women

RelatedReports

Weekly Rewinds

2 Minute Medicine Rewind July 7, 2025

July 7, 2025
Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease

July 7, 2025
Lessons from real-world implementation of lung cancer screening
Oncology

Tumor-infiltrating clonal hematopoiesis is associated with NSCLC recurrence

July 7, 2025
Provision of medically-tailored meals linked with lower admissions and medical spending
Chronic Disease

Time-restricted eating does not confer changes in sleep, mood, or quality of life

July 4, 2025
Next Post
High dose antidepressants may increase self-harm risk among children, young adults

Adverse childhood experiences and current life stressors may moderate the relationship between depression and C-reactive protein in midlife women

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!

The Scan by 2 Minute Medicine®: Shohei Sidelined? Blue Light Bust, Sciatica Struggles, and Concussion Effects

Low achievement of guideline-recommended diabetes targets in Chinese adults

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind July 7, 2025
  • Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease
  • Body mass index-specific waist circumference thresholds may improve mortality risk stratification in women
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.